APG Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.36M | Sell |
|
|||||
|
2025
Q1 | $12.2M | Buy |
|
|||||
|
2024
Q4 | $8.44M | Buy |
|
|||||
|
2024
Q3 | $1.22M | Sell |
|
|||||
|
2024
Q2 | $25.7M | Sell |
|
|||||
|
2024
Q1 | $32.4M | Sell |
|
|||||
|
2023
Q4 | $36.5M | Buy |
|
|||||
|
2023
Q3 | $36.2M | Sell |
|
|||||
|
2023
Q2 | $34.1M | Sell |
|
|||||
|
2023
Q1 | $39.5M | Sell |
|
|||||
|
2022
Q4 | $48.6M | Buy |
|
|||||
|
2022
Q3 | $28M | Sell |
|
|||||
|
2022
Q2 | $39.6M | Sell |
|
|||||
|
2022
Q1 | $36.3M | Sell |
|
|||||
|
2021
Q4 | $40.8M | Buy |
|
|||||
|
2021
Q3 | $9.77M | Sell |
|
|||||
|
2021
Q2 | $10.6M | Sell |
|
|||||
|
2021
Q1 | $35.3M | Buy |
|
|||||
|
2020
Q4 | $31.5M | Buy |
|
|||||
|
2020
Q3 | $21.3M | Buy |
|
|||||
|
2020
Q2 | $33M | Buy |
|
|||||
|
2020
Q1 | $21.6M | Buy |
|
|||||
|
2019
Q4 | $14M | Hold |
|
|||||
|
2019
Q3 | $11.5M | Buy |
|
|||||
|
2019
Q2 | $5.87M | Buy |
|
|||||
|
2019
Q1 | $5.04M | Hold |
|
|||||
|
2018
Q4 | $4.74M | Sell |
|
|||||
|
2018
Q3 | $5.38M | Hold |
|
|||||
|
2018
Q2 | $5.2M | Sell |
|
|||||
|
2018
Q1 | $4.79M | Hold |
|
|||||
|
2017
Q4 | $5.4M | Buy |
|
|||||
|
2017
Q3 | $6.75M | Buy |
|
|||||
|
2017
Q2 | $4.89M | Sell |
|
|||||
|
2017
Q1 | $10.9M | Sell |
|
|||||
|
2016
Q4 | $16.2M | Sell |
|
|||||
|
2016
Q3 | $22M | Buy |
|
|||||
|
2016
Q2 | $15.9M | Buy |
|
|||||
|
2016
Q1 | $14.2M | Buy |
|
|||||
|
2015
Q4 | $16.4M | Sell |
|
|||||
|
2015
Q3 | $18.9M | Sell |
|
|||||
|
2015
Q2 | $26.1M | Buy |
|
|||||
|
2015
Q1 | $16.3M | Sell |
|
|||||
|
2014
Q4 | $14M | Sell |
|
|||||
|
2014
Q3 | $13.9M | Sell |
|
|||||
|
2014
Q2 | $12.2M | Buy |
|
|||||
|
2014
Q1 | $7.15M | Buy |
|
|||||
|
2013
Q4 | $4.05M | Buy |
|
|||||
|
2013
Q3 | $3.19M | Sell |
|
|||||
|
2013
Q2 | $3.13M | Buy |
|